861 / 1851
FUTURE DIRECTION:
combination of molecular signatures with new drugs
Sulkowski PL. et al. Sci Transl. Med. 2017;9
IDH mutant tumor cells are sensitive to PARP inhibitors
|
|
861 / 1851
FUTURE DIRECTION:
combination of molecular signatures with new drugs
Sulkowski PL. et al. Sci Transl. Med. 2017;9
IDH mutant tumor cells are sensitive to PARP inhibitors